← Back to patent-cliff list
CAS 960254-02-8
5-(2-aminophenyl)-1-isobutyl-1H-imidazole-4-carbonitrile
Codes: IMIQ-022
Application context (from source-drug indications)
Actinic keratosisImiquimod尖锐湿疣Imiquimod角化病ImiquimodBasal cell carcinomaImiquimod巨大尖锐湿疣Imiquimod人乳头瘤病毒感染Imiquimod
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Imiquimod | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2-methylpropan-1-amine→2-aminomalononitrile 4-methylbenzenesulfonate→5-amino-1-isobutyl-1H-imidazole-4-carbonitrile→5-iodo-1-isobutyl-1H-imidazole-4-carbonitrile→2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline→5-(2-aminophenyl)-1-isobutyl-1H-imidazole-4-carbonitrile
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.